Find Suvorexant manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

0

EU WC

0

KDMF

0

VMF

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

Europe

0

Canada

0

Australia

0

South Africa

0

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

136RELATED EXCIPIENT COMPANIES

209EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Exclusivities

API/FDF Prices: Book a Demo

API REF. PRICE (USD/KG)

GLOBAL SALES INFORMATION

Regulatory FDF Prices

NA

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 1030377-33-3, Mk-4305, Belsomra, Mk4305, Mk 4305, [(7r)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2h-1,2,3-triazol-2-yl)phenyl]methanone
Molecular Formula
C23H23ClN6O2
Molecular Weight
450.9  g/mol
InChI Key
JYTNQNCOQXFQPK-MRXNPFEDSA-N
FDA UNII
081L192FO9

Suvorexant
Suvorexant is a selective dual antagonist of orexin receptors OX1R and OX2R that promotes sleep by reducing wakefulness and arousal. It has been approved for the treatment of insomnia.
Suvorexant is an Orexin Receptor Antagonist. The mechanism of action of suvorexant is as an Orexin Receptor Antagonist, and P-Glycoprotein Inhibitor, and Cytochrome P450 3A Inhibitor.
1 2D Structure

Suvorexant

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone
2.1.2 InChI
InChI=1S/C23H23ClN6O2/c1-15-3-5-20(30-25-8-9-26-30)18(13-15)22(31)29-12-11-28(10-7-16(29)2)23-27-19-14-17(24)4-6-21(19)32-23/h3-6,8-9,13-14,16H,7,10-12H2,1-2H3/t16-/m1/s1
2.1.3 InChI Key
JYTNQNCOQXFQPK-MRXNPFEDSA-N
2.1.4 Canonical SMILES
CC1CCN(CCN1C(=O)C2=C(C=CC(=C2)C)N3N=CC=N3)C4=NC5=C(O4)C=CC(=C5)Cl
2.1.5 Isomeric SMILES
C[C@@H]1CCN(CCN1C(=O)C2=C(C=CC(=C2)C)N3N=CC=N3)C4=NC5=C(O4)C=CC(=C5)Cl
2.2 Other Identifiers
2.2.1 UNII
081L192FO9
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone

2. Belsomra

3. Methanone, ((7r)-4-(5-chloro-2-benzoxazolyl)hexahydro-7-methyl-1h-1,4-diazepin-1-yl)(5-methyl-2-(2h-1,2,3-triazol-2-yl)phenyl)-

4. Mk 4305

5. Mk-4305

6. Mk4305

2.3.2 Depositor-Supplied Synonyms

1. 1030377-33-3

2. Mk-4305

3. Belsomra

4. Mk4305

5. Mk 4305

6. [(7r)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2h-1,2,3-triazol-2-yl)phenyl]methanone

7. Suvorexant (mk-4305)

8. 5-chloro-2-[(5r)-5-methyl-4-[5-methyl-2-(2h-1,2,3-triazol-2-yl)benzoyl]-1,4-diazepan-1-yl]-1,3-benzoxazole

9. Chembl1083659

10. Chebi:82698

11. 081l192fo9

12. ((7r)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone

13. Methanone, ((7r)-4-(5-chloro-2-benzoxazolyl)hexahydro-7-methyl-1h-1,4-diazepin-1-yl)(5-methyl-2-(2h-1,2,3-triazol-2-yl)phenyl)-

14. (r)-(4-(5-chlorobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone.

15. [(7r)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone

16. Suvorexant [usan:inn]

17. Dora-analogue

18. Unii-081l192fo9

19. Belsomra (tn)

20. Suv

21. Suvorexant [mi]

22. Suvorexant [inn]

23. Suvorexant [jan]

24. Suvorexant (jan/usan)

25. Suvorexant [usan]

26. Suvorexant; Mk 4305

27. Suvorexant [vandf]

28. Suvorexant [who-dd]

29. Amy337

30. Gtpl2890

31. Schembl1586289

32. Suvorexant [orange Book]

33. Dtxsid90145616

34. Ex-a211

35. Belsomra Component Suvorexant

36. Bdbm50318701

37. Mfcd22377755

38. Zinc49036447

39. Akos022185167

40. Cs-0614

41. Db09034

42. Suvorexant Component Of Belsomra

43. (4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone

44. Ac-30276

45. As-74879

46. Hy-10807

47. Bcp0726000197

48. Ft-0697203

49. Sw219649-1

50. D10082

51. J-690010

52. Q7650517

53. Cas:1030377-33-3;mk-4305

54. 5-chloro-2-[(5r)-5-methyl-4-[5-methyl-2-(2h-1,2,3-triazol-2-yl)benzoyl]-1,4-diazepan-1-yl]-1,3-benzoxazole Mk 4305

2.4 Create Date
2008-10-20
3 Chemical and Physical Properties
Molecular Weight 450.9 g/mol
Molecular Formula C23H23ClN6O2
XLogP34.9
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count6
Rotatable Bond Count3
Exact Mass450.1571017 g/mol
Monoisotopic Mass450.1571017 g/mol
Topological Polar Surface Area80.3 Ų
Heavy Atom Count32
Formal Charge0
Complexity664
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Suvorexant is indicated for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance.


FDA Label


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Orexin Receptor Antagonists

Substances that bind to and inhibit the action of OREXIN RECEPTORS. Drugs in this class have been used as SLEEP AIDS, PHARMACEUTICAL. (See all compounds classified as Orexin Receptor Antagonists.)


Sleep Aids, Pharmaceutical

Drugs used to induce SLEEP, prevent SLEEPLESSNESS, or treat SLEEP INITIATION AND MAINTENANCE DISORDERS. (See all compounds classified as Sleep Aids, Pharmaceutical.)


5.2 FDA Pharmacological Classification
5.2.1 Active Moiety
SUVOREXANT
5.2.2 FDA UNII
081L192FO9
5.2.3 Pharmacological Classes
Orexin Receptor Antagonist [EPC]; Orexin Receptor Antagonists [MoA]; P-Glycoprotein Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]
5.3 ATC Code

N - Nervous system

N05 - Psycholeptics

N05C - Hypnotics and sedatives

N05CM - Other hypnotics and sedatives

N05CM19 - Suvorexant


5.4 Absorption, Distribution and Excretion

Absorption

Peak concentrations occur at a median Tmax of 2 hours under fasted conditions. Ingestion of suvorexant with a high-fat meal has no effect on AUC or Cmax, but may delay Tmax by approximately 1.5 hours. Mean absolute bioavailability of 10 mg is 82%.


Route of Elimination

Approximately 66% is eliminated in feces and 23% is eliminated in urine.


Volume of Distribution

Mean volume of distribution is approximately 49 litres.


5.5 Metabolism/Metabolites

Suvorexant is primarily metabolized by cytochrome-P450 3A4 enzyme (CYP3A4) with a minor contribution from CYP2C19. Major circulating metabolites are suvorexant and a hydroxy-suvorexant metabolite, which is not expected to be pharmacologically active. There is potential for drug-drug interactions with drugs that inhibit or induce CYP3A4 activity.


5.6 Biological Half-Life

Mean half life is approximately 12 hours.


5.7 Mechanism of Action

Suvorexant is a dual antagonist of orexin receptors OX1R and OX2R. It exerts its pharmacological effect by inhibiting binding of neuropeptides orexin A and B, also known as hypocretin 1 and 2, that are produced by neurons in the lateral hypothalamus. These neurons control the wake-promoting centers of the brain and are active during wakefulness, especially during motor activities, and stop firing during sleep. By inhibiting the reinforcement of arousal systems, suvorexant use causes a decrease in arousal and wakefulness, rather than having a direct sleep-promoting effect.


Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Flag India
Digital Content Digital Content

Suvorexant

About the Company : Biophore, founded in 2007, develops and manufactures niche and complex pharmaceutical products. With USFDA- and EU-approved API facilities, a dedicated intermediates site and an R&...

Biophore, founded in 2007, develops and manufactures niche and complex pharmaceutical products. With USFDA- and EU-approved API facilities, a dedicated intermediates site and an R&D center of 400 scientists, the company is a leading global API player. Biophore ranks among the top US DMF filers, holds 150+ patents and maintains a strong compliance record with major regulatory agencies. Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Biophore

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Flag India
Digital Content Digital Content

Suvorexant

About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...

Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product groups and has been approved by ISO 9001-2015, USFDA, WHO GMP, Cofepris & Japanese authorities. Metrochem’s in-depth industry knowledge, & hi-tech & advanced infrastructure, helps it provide quality products to its customers. Note: None of the products will be supplied to the countries where this could conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer
Metrochem

03

BioProcess International
Not Confirmed
arrow
arrow
BioProcess International
Not Confirmed

Suvorexant

About the Company : Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutica...

Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates.
blank

04

BioProcess International
Not Confirmed
arrow
arrow
BioProcess International
Not Confirmed

Suvorexant

About the Company : Bajaj Healthcare Ltd. is a company established in 1993, services various Pharmaceuticals, Nutraceutical and Food industries globally with a spirit of scrupulousness. Bajaj Healt...

Bajaj Healthcare Ltd. is a company established in 1993, services various Pharmaceuticals, Nutraceutical and Food industries globally with a spirit of scrupulousness. Bajaj Healthcare Ltd. have metamorphosed into specialty company and focused on development, manufacturing and supply of Amino Acids, Nutritional Supplements and Active Pharmaceutical Ingredients (API) for Pharmaceutical, Nutraceuticals and Food industries. Bajaj healthcare Ltd. in its shot life span has gained loyalty from national and international customers and our products enjoy good fame in the overseas market.
blank

05

DEAFARMA

Italy
BioProcess International
Not Confirmed
arrow

DEAFARMA

Italy
arrow
BioProcess International
Not Confirmed

Suvorexant

About the Company : In the dinamic pharmaceutical field, DEAFARMA is the reference point for primaries Pharmaceutical Laboratories for over twenty years, even in the national and international territo...

In the dinamic pharmaceutical field, DEAFARMA is the reference point for primaries Pharmaceutical Laboratories for over twenty years, even in the national and international territory. DEAFARMA works with success in the pharmaceutical raw materials field through Agencies and professional relations with the most important European and Asiatic factories. Our partners are well known, reliable producers and all of them are operating in accordance with the latest GMP Rules. The APIs mentioned in the DEAFARMA catalogue are always supported by DMF and/or CEP.
blank

06

BioProcess International
Not Confirmed
arrow
arrow
BioProcess International
Not Confirmed

Suvorexant

About the Company : Established in 2011 and situated in Hangzhou, Zhejiang, China, Hangzhou Longshine Bio-Tech CO., Ltd is dedicated to providing services for pharmaceutical and chemical products, cat...

Established in 2011 and situated in Hangzhou, Zhejiang, China, Hangzhou Longshine Bio-Tech CO., Ltd is dedicated to providing services for pharmaceutical and chemical products, catering to both export and import markets. The company consists of two primary business departments: the Professional Sourcing/Product Team and the Quality Team. Backed by experienced partners, Longshine has evolved into a trustworthy supplier of high-quality products and received ISO9001:2008 certification in 2017.
blank

07

BioProcess International
Not Confirmed
arrow
arrow
BioProcess International
Not Confirmed

Suvorexant

About the Company : Saptagir Laboratories Private incorporated in 2016, is a manufacturer and supplier of Active Pharmaceutical Ingredients (APIs) and Intermediates for a wide range of therapeutic cat...

Saptagir Laboratories Private incorporated in 2016, is a manufacturer and supplier of Active Pharmaceutical Ingredients (APIs) and Intermediates for a wide range of therapeutic categories specifically focusing on Anti-Fungal and Anti-Platelets. Our vision is to attain market leadership in development of innovator molecules for the domestic and export market.
blank

08

BioProcess International
Not Confirmed
arrow
arrow
BioProcess International
Not Confirmed

Suvorexant

About the Company : SMS Pharmaceuticals Ltd. is a global player in API manufacturing having a strong research and manufacturing team supported by state of the art facilities. What started off as a sin...

SMS Pharmaceuticals Ltd. is a global player in API manufacturing having a strong research and manufacturing team supported by state of the art facilities. What started off as a single facility - single product manufacturing company in 1990 grew to be a multi-location group having product list spreading across an array of therapeutic segments. SMS was given the export house status in the year 1997-98. SMS is currently a listed company having ever appreciating international and domestic customer base.
blank

09

BioProcess International
Not Confirmed
arrow
arrow
BioProcess International
Not Confirmed

Suvorexant

About the Company : Torrent Pharma is part of 3 billion USD Torrent group; we are leading conglomerate from India, having presence across 40 countries including USA, Brazil, Europe, and Mexico & India...

Torrent Pharma is part of 3 billion USD Torrent group; we are leading conglomerate from India, having presence across 40 countries including USA, Brazil, Europe, and Mexico & India. Over the years, Torrent forayed into Dermatology & Oncology segment for which Torrent is actively looking for partners to provide Contract Manufacturing Services for India as well as Global markets. Torrent has state of the art manufacturing facility based in India and has capability to handle various types of Derma & Onco products with available capacity of more than 150 Mn units & 50 Mn units per Annum respectively.
blank

10

Viatris

U.S.A
BioProcess International
Not Confirmed
arrow

Viatris

U.S.A
arrow
BioProcess International
Not Confirmed

Suvorexant

About the Company : In November 2020, Viatris was formed through the combination of Mylan and Upjohn, with a mission of empowering people worldwide to live healthier at every stage of life. Viatris (N...

In November 2020, Viatris was formed through the combination of Mylan and Upjohn, with a mission of empowering people worldwide to live healthier at every stage of life. Viatris (NASDAQ: VTRS) is a global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1666204200,"product":"SUVOREXANT (FORM-II)","address":"8-3-166\/182, A BLOCK, NORTH WING,, 105-108, IST FLOOR CHALLA ESTATES,","city":"ERRADADDA,TELANGANA","supplier":"DASAMI LAB PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"TAIPEI","customer":"UNDISCLOSED","customerCountry":"TAIWAN","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"22000","totalValueFC":"21523","currency":"USD","unitRateINR":1771000,"date":"20-Oct-2022","totalValueINR":"1771000","totalValueInUsd":"21523","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"4975024","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"8-3-166\/182, A BLOCK, NORTH WING,, 105-108, IST FLOOR CHALLA ESTATES,, ERRADADDA,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1677868200,"product":"PHARMACEUTICAL RAW MATERIAL: SUVOREXANT","address":"PLOT NO.C-24,INDUSTRIAL ESTATE, SANATHNAGAR CONTACT NO: 91966610210","city":"HYDERABAD","supplier":"MAITHRI LABORATORIES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"CHARLOTTE, NC","customer":"UNDISCLOSED","customerCountry":"UNITED STATES","quantity":"0.01","actualQuantity":"0.01","unit":"KGS","unitRateFc":"100000","totalValueFC":"802.4","currency":"USD","unitRateINR":6600000,"date":"04-Mar-2023","totalValueINR":"66000","totalValueInUsd":"802.4","indian_port":"HYDERABAD AIR","hs_no":"29225090","bill_no":"8250448","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOT NO.C-24,INDUSTRIAL ESTATE, SANATHNAGAR CONTACT NO: 91966610210, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1679337000,"product":"SUVOREXANT [(7R)-4-(5-CHLORO-1,3-BENZOXA","address":"ALEMBIC ROAD VADODARA CONTACT NO: 919727727339","city":"GUJARAT","supplier":"ALEMBIC PHARMACEUTICALS LTD","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"MONTE VERDE S A","customerCountry":"ARGENTINA","quantity":"0.35","actualQuantity":"0.35","unit":"KGS","unitRateFc":"69000","totalValueFC":"22857","currency":"USD","unitRateINR":5371428.5714285718,"date":"21-Mar-2023","totalValueINR":"1880000","totalValueInUsd":"22857","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"8632586","productDescription":"API","marketType":"","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"ALEMBIC ROAD VADODARA CONTACT NO: 919727727339, GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1692815400,"product":"SUVOREXANT\/ DCO (5 MG)","address":"H.NO.8-3-166\/7\/1 HETERO HOUSEER RAGADDA","city":"Hyderabad","supplier":"HONOUR LAB LTD","supplierCountry":"INDIA","foreign_port":"NA","customer":"UNDISCLOSED","customerCountry":"TAIWAN","quantity":"0.07","actualQuantity":"0.065","unit":"KGS","unitRateFc":"6737.8","totalValueFC":"434.6","currency":"USD","unitRateINR":553845.8953846154,"date":"24-Aug-2023","totalValueINR":"35999.9832","totalValueInUsd":"434.6","indian_port":"HYDERABAD ICD","hs_no":"29339990","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD ICD","supplierAddress":"H.NO.8-3-166\/7\/1 HETERO HOUSEER RAGADDA, Hyderabad","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1692815400,"product":"SUVOREXANT\/ REGIOISOMER (5 MG)","address":"H.NO.8-3-166\/7\/1 HETERO HOUSEER RAGADDA","city":"Hyderabad","supplier":"HONOUR LAB LTD","supplierCountry":"INDIA","foreign_port":"NA","customer":"UNDISCLOSED","customerCountry":"TAIWAN","quantity":"0.07","actualQuantity":"0.065","unit":"KGS","unitRateFc":"6737.8","totalValueFC":"434.6","currency":"USD","unitRateINR":553845.8953846154,"date":"24-Aug-2023","totalValueINR":"35999.9832","totalValueInUsd":"434.6","indian_port":"HYDERABAD ICD","hs_no":"29339990","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD ICD","supplierAddress":"H.NO.8-3-166\/7\/1 HETERO HOUSEER RAGADDA, Hyderabad","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1703183400,"product":"SUVOREXANT (FORM-II) IN-HOUSE","address":"8-3-166\/182, A BLOCK, NORTH WING,,","city":"ERRADADDA,TELANGANA","supplier":"DASAMI LAB PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"APOTEX INC SIGNET","customerCountry":"CANADA","quantity":"0.25","actualQuantity":"0.25","unit":"KGS","unitRateFc":"25000","totalValueFC":"6186.7","currency":"USD","unitRateINR":2060000,"date":"22-Dec-2023","totalValueINR":"515000","totalValueInUsd":"6186.7","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"6225788","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"8-3-166\/182, A BLOCK, NORTH WING,,, ERRADADDA,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1705689000,"product":"SUVOREXANT (FORM - II) IN-HOUSE","address":"8-3-166\/182, A BLOCK, NORTH WING,,","city":"ERRADADDA,TELANGANA","supplier":"DASAMI LAB PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"OSAKA","customer":"TOWA PHARMACEUTICAL COLTD","customerCountry":"JAPAN","quantity":"0.40","actualQuantity":"0.4","unit":"KGS","unitRateFc":"25000","totalValueFC":"9877.4","currency":"USD","unitRateINR":2052322.5,"date":"20-Jan-2024","totalValueINR":"820929","totalValueInUsd":"9877.4","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"6899362","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"8-3-166\/182, A BLOCK, NORTH WING,,, ERRADADDA,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1725993000,"product":"SUVOREXANT","address":"8-3-166\/182, A BLOCK, NORTH WING,,","city":"ERRADADDA,TELANGANA","supplier":"DASAMI LAB PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"TAIPEI","customer":"CAMBER PHARMACEUTICAL COLTD","customerCountry":"TAIWAN","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"22000","totalValueFC":"21794.5","currency":"USD","unitRateINR":1826408,"date":"11-Sep-2024","totalValueINR":"1826408","totalValueInUsd":"21794.5","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"3927015","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"8-3-166\/182, A BLOCK, NORTH WING,,, ERRADADDA,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1735583400,"product":"SUVOREXANT (FORM-II)","address":"8-3-166\/182, A BLOCK, NORTH WING,,","city":"ERRADADDA,TELANGANA","supplier":"DASAMI LAB PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"OSAKA - KANSAI INT\\'L","customer":"TOWA PHARMACEUTICAL COLTD","customerCountry":"JAPAN","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"21898.9","totalValueFC":"10856.8","currency":"USD","unitRateINR":1844980,"date":"31-Dec-2024","totalValueINR":"922490","totalValueInUsd":"10856.8","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"6908182","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"8-3-166\/182, A BLOCK, NORTH WING,,, ERRADADDA,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1736101800,"product":"SUVOREXANT (FORM-II)","address":"8-3-166\/182, A BLOCK, NORTH WING,,","city":"ERRADADDA,TELANGANA","supplier":"DASAMI LAB PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"HO CHI MINH C","customer":"HERA BIOPHARMACEUTICAL CO LTD","customerCountry":"VIETNAM","quantity":"0.25","actualQuantity":"0.25","unit":"KGS","unitRateFc":"23000","totalValueFC":"5635.6","currency":"USD","unitRateINR":1943812.24,"date":"06-Jan-2025","totalValueINR":"485953.06","totalValueInUsd":"5635.6","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"7047627","productDescription":"API","marketType":"","country":"VIETNAM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"8-3-166\/182, A BLOCK, NORTH WING,,, ERRADADDA,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1739298600,"product":"SUVOREXANT (FORM-II)","address":"8-3-166\/182, A BLOCK, NORTH WING,,","city":"ERRADADDA,TELANGANA","supplier":"DASAMI LAB PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"TAIPEI","customer":"UNDISCLOSED","customerCountry":"TAIWAN","quantity":"0.10","actualQuantity":"100","unit":"GMS","unitRateFc":"43000","totalValueFC":"4255.5","currency":"USD","unitRateINR":3700.7800000000002,"date":"12-Feb-2025","totalValueINR":"370078","totalValueInUsd":"4255.5","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"8090298","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"8-3-166\/182, A BLOCK, NORTH WING,,, ERRADADDA,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1743186600,"product":"SUVOREXANT (FORM-II) (FREE SAMPLES)","address":"8-3-166\/182, A BLOCK, NORTH WING,,","city":"ERRADADDA,TELANGANA","supplier":"DASAMI LAB PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"TOKYO","customer":"CBC CO LTD","customerCountry":"JAPAN","quantity":"0.05","actualQuantity":"0.05","unit":"KGS","unitRateFc":"10000","totalValueFC":"438.1","currency":"USD","unitRateINR":759000,"date":"29-Mar-2025","totalValueINR":"37950","totalValueInUsd":"438.1","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"9494871","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"8-3-166\/182, A BLOCK, NORTH WING,,, ERRADADDA,TELANGANA","customerAddress":""}]
20-Oct-2022
29-Mar-2025
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Coating Systems & Additives

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Direct Compression

read-more
read-more

Granulation

read-more
read-more

Controlled & Modified Release

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Lubricants & Glidants

read-more
read-more

Co-Processed Excipients

read-more
read-more

Taste Masking

read-more
read-more

Empty Capsules

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Vegetarian Capsules

read-more
read-more

API Stability Enhancers

read-more
read-more

Solubilizers

read-more
read-more

Emulsifying Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Coloring Agents

read-more
read-more

Parenteral

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Looking for 1030377-33-3 / Suvorexant API manufacturers, exporters & distributors?

Suvorexant manufacturers, exporters & distributors 1

23

PharmaCompass offers a list of Suvorexant API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Suvorexant manufacturer or Suvorexant supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Suvorexant manufacturer or Suvorexant supplier.

PharmaCompass also assists you with knowing the Suvorexant API Price utilized in the formulation of products. Suvorexant API Price is not always fixed or binding as the Suvorexant Price is obtained through a variety of data sources. The Suvorexant Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Suvorexant

Synonyms

1030377-33-3, Mk-4305, Belsomra, Mk4305, Mk 4305, [(7r)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2h-1,2,3-triazol-2-yl)phenyl]methanone

Cas Number

1030377-33-3

Unique Ingredient Identifier (UNII)

081L192FO9

About Suvorexant

Suvorexant is a selective dual antagonist of orexin receptors OX1R and OX2R that promotes sleep by reducing wakefulness and arousal. It has been approved for the treatment of insomnia.

Suvorexant; MK 4305 Manufacturers

A Suvorexant; MK 4305 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Suvorexant; MK 4305, including repackagers and relabelers. The FDA regulates Suvorexant; MK 4305 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Suvorexant; MK 4305 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Suvorexant; MK 4305 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Suvorexant; MK 4305 Suppliers

A Suvorexant; MK 4305 supplier is an individual or a company that provides Suvorexant; MK 4305 active pharmaceutical ingredient (API) or Suvorexant; MK 4305 finished formulations upon request. The Suvorexant; MK 4305 suppliers may include Suvorexant; MK 4305 API manufacturers, exporters, distributors and traders.

click here to find a list of Suvorexant; MK 4305 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Suvorexant; MK 4305 USDMF

A Suvorexant; MK 4305 DMF (Drug Master File) is a document detailing the whole manufacturing process of Suvorexant; MK 4305 active pharmaceutical ingredient (API) in detail. Different forms of Suvorexant; MK 4305 DMFs exist exist since differing nations have different regulations, such as Suvorexant; MK 4305 USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Suvorexant; MK 4305 DMF submitted to regulatory agencies in the US is known as a USDMF. Suvorexant; MK 4305 USDMF includes data on Suvorexant; MK 4305's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Suvorexant; MK 4305 USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Suvorexant; MK 4305 suppliers with USDMF on PharmaCompass.

Suvorexant; MK 4305 JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Suvorexant; MK 4305 Drug Master File in Japan (Suvorexant; MK 4305 JDMF) empowers Suvorexant; MK 4305 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Suvorexant; MK 4305 JDMF during the approval evaluation for pharmaceutical products. At the time of Suvorexant; MK 4305 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Suvorexant; MK 4305 suppliers with JDMF on PharmaCompass.

Suvorexant; MK 4305 NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Suvorexant; MK 4305 as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Suvorexant; MK 4305 API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Suvorexant; MK 4305 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Suvorexant; MK 4305 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Suvorexant; MK 4305 NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Suvorexant; MK 4305 suppliers with NDC on PharmaCompass.

Suvorexant; MK 4305 GMP

Suvorexant; MK 4305 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Suvorexant; MK 4305 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Suvorexant; MK 4305 GMP manufacturer or Suvorexant; MK 4305 GMP API supplier for your needs.

Suvorexant; MK 4305 CoA

A Suvorexant; MK 4305 CoA (Certificate of Analysis) is a formal document that attests to Suvorexant; MK 4305's compliance with Suvorexant; MK 4305 specifications and serves as a tool for batch-level quality control.

Suvorexant; MK 4305 CoA mostly includes findings from lab analyses of a specific batch. For each Suvorexant; MK 4305 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Suvorexant; MK 4305 may be tested according to a variety of international standards, such as European Pharmacopoeia (Suvorexant; MK 4305 EP), Suvorexant; MK 4305 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Suvorexant; MK 4305 USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty